2M BioTech leverages a network of advisors with broad expertise in drug development, financing, patent protection, start-up development, marketing and communications to customize the right path to product development.
Morton H. Meyerson
Morton began his business career in 1963 at Bell Helicopter. In 1966, he joined Electronic Data Systems, Inc. as a systems engineer trainee, ultimately becoming President and Vice Chairman and managing 45,000 employees. In 1984, Morton played a significant role in the sale of EDS to General Motors for $2.5 billion, becoming the top technology officer at General Motors. Two years after the sale to General Motors, after growing EDS revenue four-fold, Morton retired. From 1971 through 1974, during his tenure at EDS and at the age of 33, Morton was the Chief Executive Officer and Chairman of duPont Glore Forgan, a Wall Street brokerage firm.
From 1986 through 1992, Morton pursued private investment opportunities with Richard Rainwater. In 1992, at the request of Ross Perot, Morton re–joined the corporate world as Chief Executive Officer and Chairman of Perot Systems Corporation, retiring again in 1998.
Currently, Morton is the Chairman of 2M Companies, Inc. a family owned investment firm. From time to time, Morton has served on public and private company boards. Currently, Morton is a director of E2M Partners, LLC, Alsbridge Inc., ChaCha Search, Inc., Cebatech, Inc., and KDC Holdings, LLC. Morton was elected into The American Academy of Arts & Sciences 2007 Class of Fellows.
Elaine White has extensive experience in technology transfer/commercialization, and has worked in this field from 1995-present. She began her technology transfer career at the National Institutes of Health, and subsequently worked at the Massachusetts General Hospital and at Boston College, negotiating a broad range of agreements at each. Most recently, Elaine was the Associate Director of Technology Transfer & Commercialization at the University of North Texas Health Science Center in Fort Worth. She has also performed considerable technology commercialization work for Foresight Science & Technology.
Prior to joining the National Institutes of Health, Elaine White obtained an M.B.A. in Finance from New York University’s Stern School of Business, with additional concentrations in Marketing and Business Strategy; she also holds a Master’s degree in Biology from UCLA. Prior to her M.B.A. studies, Elaine conducted research in Drosophila genetics in the laboratory of Nobel laureate Dr. Edward B. Lewis and in molecular biology/immunology in the laboratory of Dr. Leroy Hood, both at the California Institute of Technology.
In addition to her ongoing work in technology commercialization, Elaine has been very active in the Licensing Executives Society, where she has served on the Board of Trustees for the LES Foundation, as Chair of the LES Industry-University-Government Interface Sector, and as a member of the Editorial Board for LES Insights. She has also been active in the Association of University Technology Managers (AUTM).
Ian Trumpower is the President of 2M Companies, Inc. In that role Ian manages numerous portfolio investments in the technology sector. Ian is a director of Alpha Dominche Holdings, Inc. and Cebatech, Inc. and has served as a director on various other boards including ChaCha Search, Inc.
Prior to joining 2M Companies, Ian was associate general counsel for HBK Capital Management, a multi-billion dollar hedge fund. Prior to joining HBK, Ian practiced law with Weil, Gotshal & Manges and with Akin Gump Strauss Hauer & Feld, focusing on venture capital financing, mergers and acquisitions and corporate finance. Ian earned an accounting degree and juris doctor degree from the University of Illinois and is a licensed attorney and an inactive certified public accountant. Prior to becoming a lawyer, Ian served in the United States Marine Corps.
Dr. Solomon Snyder
Dr. Solomon Snyder joined the faculty of the Johns Hopkins University School of Medicine as an Assistant Professor of Pharmacology in 1996. He subsequently established the Department of Neuroscience and served as its Director from 1980-2006. He is presently Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry.
Dr. Snyder is the recipient of numerous professional honors, including the Albert Lasker Award for Basic Biomedical Research (1978), the National Medal of Science (2003), the Albany Medical Prize (2007), and multiple Honorary Doctor of Science degrees. He was also awarded the Wolf Foundation Prize in Medicine (1983), the Dickson Prize of the University of Pittsburgh (1984), the Bower Award of the Franklin Institute (1991), the Bristol-Myers Squibb Award for Distinguished Achievement in Neuroscience Research (1996) and the Gerard Prize of the Society for Neuroscience (2000). He is a member of the United States National Academy of Sciences and a Fellow of the American Academy of Arts and Sciences and the American Philosophical Society. He is the author of more than 1000 journal articles and several books. Many important advances in molecular neuroscience have stemmed from Dr. Snyder's work.
Joe Boyd has nearly 30 years of information technology experience. Joe began his IT career with Electronic Data Systems in the State and Local Government Healthcare Group. After leaving EDS, he worked in the healthcare practices of KPMG Peat Marwick and GTE before joining Perot Systems in 1990. At Perot Systems, Joe progressed through a variety of positions and was named Vice President and General Manager for the Healthcare Industry practice in 1994. In 1997, Joe was promoted to Executive Vice President and General Manager for Perot Systems North American sales and operations, directing over 4,000 employees in a $600M business that included seven industry verticals. Joe retired from Perot Systems in 2001 but has continued to be involved in the industry providing management consulting and executive coaching services through his own firm, Boyd Consulting.
Joe served as the Chairman of Healthlink Inc. from 2003 until it was sold to IBM in June, 2005. Joe also actively serves as a director at OnFocus|Healthcare, MediSend International and is the current Chairman of MedSynergies Inc. – a Physician Alignment and RCM company based in Irving, TX.
Joe holds a B.A. in History and an M.B.A. from Mississippi State University.
Tom Luce is the CEO of the National Math and Science Initiative, a non-profit organization formed in 2007 to improve math and science achievement in America’s public schools. Mr. Luce served as United States Assistant Secretary of Education for Planning, Evaluation and Policy Development during 2005 and 2006. Mr. Luce was a co-founder of the National Center for Educational Accountability and also founded Communities Just for the Kids.
An attorney, Tom Luce received his undergraduate and graduate degrees from Southern Methodist University and has been honored with the SMU Law School and University Distinguished Alumni Awards. He was a founding partner and managing partner of the law firm of Hughes & Luce, LLP until his retirement from the firm in 1997.
In addition to his active law practice, at various times Mr. Luce has served on the boards or as guest lecturer at a number of schools of higher education, including the Kennedy School of Government at Harvard, the LBJ School of Public Affairs at The University of Texas at Austin, and Southern Methodist University.
Following his service in the Department of Education, Mr. Luce rejoined the board of Dell Inc. He is the longest serving outside member, having previously served on the Dell board from 1991 until 2005. He also has served on the boards of the Texas Education Reform Caucus and multiple community and charitable organizations. He served as a member of the National Commission on Teaching and America's Future and on the Executive Committee of the Dallas Citizens Council, an organization composed of CEOs of Dallas' largest businesses. In addition, the United States Senate appointed Mr. Luce a member of the Library of Congress Trust Fund Board where he served until 2005.
Mr. Luce also has been appointed five times to major posts by Texas governors, including Chief Justice pro tempore of the Texas Supreme Court. He is perhaps best known for his role as the Chief of Staff of the Texas Select Committee of Public Education, which produced one of the first major reform efforts among public schools in 1984.
In 1995 Mr. Luce wrote Now or Never - How We Can Save Our Public Schools, a book that defined his educational philosophy and outlined a preliminary plan for educational reform that called for broader support for public education. His second book, Do What Works, was published in December 2004 to positive reviews. In fall 2009, he was named a Purpose Prize fellow, an honor presented by the Civic Ventures think tank for social entrepreneurs over 60 who are using their experience and passion to take on society’s biggest challenges.
William J. Rieflin
Mr. Rieflin currently serves as Chief Executive Officer of NGM Biopharmaceuticals, Inc., and brings over 20 years of industry experience to 2M BioTech. Prior to that, he was President of XenoPort, Inc. and currently serves on XenoPort’s Board of Directors. In addition, he is on the Board of Directors for Anacor Pharmaceuticals, Inc. Prior to joining XenoPort, he was Executive Vice President, Administration, Chief Financial Officer, General Counsel and Secretary for Tularik, Inc., which was acquired by Amgen, Inc. in 2004. Previously, he was Vice President, Human Resources, General Counsel and Secretary for AMSCO International, Inc. He was also an associate at Sidley & Austin in the corporate and securities department. He began his career as a sales representative for American Hospital Supply Corporation. Mr. Rieflin earned his B.S. from Cornell University, his M.B.A. from the University of Chicago Booth School of Business and his J.D. from Stanford Law School.